Sigma-Aldrich's Q4 Revenues Jump 12 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Sigma-Aldrich today reported fourth-quarter revenue growth of 12 percent, or nearly 6 percent on an organic basis, led by its Research Biotech and SAFC businesses.

The St.Louis-based chemicals and research tools firm reported total revenues of $572.5 million for the three-month period ended Dec. 31, 2009, compared to $509.8 million for the fourth quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.